Author year | No. eyes | Indic. | Postop time point | Type analysis | Patient age | Patient sex | Donor age | Triple DMEK | Preop BCVA | Preop ECD | Preop CCT | Mean anter. Kerat. | Rebubb. |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chauras. 2014 [2] | 492 | FECD | 6 mo | Uni/Multi. | < 0.0001a |  |  | < 0.0001b |  |  |  |  |  |
Van Dijk 2014 [3] | 118 | FECD | 6 mo | Multi. | < 0.001 | NS |  | NS | < 0.001 |  |  |  |  |
Schaub 2016 [14] | 529 | mixed | 12 mo | Univ. | Â | Â | NS | Â | Â | Â | Â | Â | Â |
Ham 2016 [18] | 250 | mixed | 6 mo | Multiv. | 0.0016 | Â | Â | Â | Â | Â | Â | Â | Â |
Schlögl 2016 [19] | 97 | mixed | 3 y | Univ. |  |  |  | NS |  |  |  |  |  |
Peraza 2017 [20] | 396 | mixed | 2 y | Multi. | 0.0012 | NS |  |  |  | NS | < 0.0001 |  | 0.0003 |
Schaub 2017 [21] | 160 | FECD | 2 y | Univ. | Â | Â | Â | Â | Â | NS | NS | Â | Â |
Neiter 2017 [22] | 19 | mixed | 6 mo | Univ. | Â | Â | Â | Â | Â | Â | NS | Â | Â |
Gerber 2017 [23] | 760 | mixed | 6 mo | Univ. | Â | Â | Â | Â | Â | Â | Â | Â | NS |
Mechels 2017 [24] | 94 | FECD | 3 mo | Univ. | Â | Â | Â | Â | Â | Â | Â | Â | NS |
Brockm. 2019 [4] | 108 | FECD | 12 mo | Univ. | Â | Â | Â | Â | NS | NS | 0.014 | Â | Â |
Schaub 2019 [5] | 1748 | mixed | 12 mo | Univ. | Â | Â | NS | Â | Â | Â | Â | Â | Â |
Schritt. 2019 [6] | 1084 | mixed | 12 mo | Univ. | Â | Â | Â | Â | 0.011 | Â | NS | Â | Â |
Godin 2019 [7] | 136 | mixed | UC | Univ. | Â | Â | Â | Â | Â | Â | Â | Â | NS |
Singh 2019 [8] | 50 | mixed | 3 mo | Univ. | Â | Â | 0.03 | NS | Â | Â | Â | Â | Â |
Shah. 2020 [9] | 114 | FECD | 12 mo | Univ. | Â | Â | Â | NS | Â | Â | Â | Â | Â |
Birbal 2020 [10] | 738 | mixed | 6 mo | Multi. | Â | Â | Â | NS | Â | Â | Â | Â | Â |
Birbal 2020 [11] | 393 | mixed | 5 y | Multi. | NS | NS |  | NS |  |  |  |  | < 0.0001 |
Besek 2022 [12] | 150 | mixed | 7 y | Multi. | 0.009 | Â | NS | NS | Â | Â | Â | Â | NS |
Gund 2021 [13] | 463 | mixed | 12 mo | Multi. | Â | Â | Â | Â | Â | Â | Â | Â | NSc |
Agha 2021 [15] | 33 | FECD | 9 mo | C-C | Â | Â | Â | Â | Â | Â | Â | Â | 0.03 |
Romano 2022 [16] | 91 | mixed | 12 mo | Univ. | Â | Â | Â | NS | Â | Â | Â | Â | NS |
Moskwa 2022 [17] | 111 | FECD | 12 mo | Univ. | Â | Â | Â | Â | Â | Â | NS | Â | Â |
Our study | 100 | FECD | 12 mo | Multi. | 0.02 | NS | NS | NS | NS | NS | NS | NS | NS |